Bio-Rad Laboratories Total Liabilities 2010-2022 | BIO.B

Bio-Rad Laboratories total liabilities from 2010 to 2022. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Bio-Rad Laboratories total liabilities for the quarter ending March 31, 2022 were $4.191B, a 26.07% increase year-over-year.
  • Bio-Rad Laboratories total liabilities for 2021 were $4.109B, a 32.85% increase from 2020.
  • Bio-Rad Laboratories total liabilities for 2020 were $3.093B, a 37.22% increase from 2019.
  • Bio-Rad Laboratories total liabilities for 2019 were $2.254B, a 41.68% increase from 2018.
Bio-Rad Laboratories Annual Total Liabilities
(Millions of US $)
2021 $4,109
2020 $3,093
2019 $2,254
2018 $1,591
2017 $1,343
2016 $1,271
2015 $1,219
2014 $1,156
2013 $1,202
2012 $1,428
2011 $1,352
2010 $1,522
2009 $1,257
Bio-Rad Laboratories Quarterly Total Liabilities
(Millions of US $)
2022-03-31 $4,191
2021-12-31 $4,109
2021-09-30 $4,621
2021-06-30 $3,523
2021-03-31 $3,324
2020-12-31 $3,093
2020-09-30 $3,196
2020-06-30 $2,744
2020-03-31 $2,391
2019-12-31 $2,254
2019-09-30 $2,046
2019-06-30 $2,160
2019-03-31 $1,999
2018-12-31 $1,591
2018-09-30 $1,818
2018-06-30 $1,747
2018-03-31 $1,727
2017-12-31 $1,343
2017-09-30 $1,337
2017-06-30 $1,332
2017-03-31 $1,245
2016-12-31 $1,271
2016-09-30 $1,317
2016-06-30 $1,260
2016-03-31 $1,209
2015-12-31 $1,219
2015-09-30 $1,237
2015-06-30 $1,166
2015-03-31 $1,128
2014-12-31 $1,156
2014-09-30 $1,209
2014-06-30 $1,218
2014-03-31 $1,209
2013-12-31 $1,202
2013-09-30 $1,156
2013-06-30 $1,412
2013-03-31 $1,426
2012-12-31 $1,428
2012-09-30 $1,368
2012-06-30 $1,316
2012-03-31 $1,348
2011-12-31 $1,352
2011-09-30 $1,276
2011-06-30 $1,318
2011-03-31 $1,295
2010-12-31 $1,522
2010-09-30 $1,254
2010-06-30 $1,224
2010-03-31 $1,246
2009-12-31 $1,257
2009-09-30 $1,251
2009-06-30 $1,217
2009-03-31 $897
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $14.907B $2.923B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $163.597B 9.95
QIAGEN (QGEN) Netherlands $10.865B 17.15
Biohaven Pharmaceutical Holding (BHVN) United States $10.248B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.228B 0.00
Arcus Biosciences (RCUS) United States $1.901B 48.18
Emergent Biosolutions (EBS) United States $1.599B 6.85
Myovant Sciences (MYOV) United Kingdom $1.236B 0.00
Zymeworks (ZYME) Canada $0.320B 0.00
Gelesis Holdings (GLS) United States $0.114B 0.00
Enzo Biochem (ENZ) United States $0.104B 0.00
Ambrx Biopharma (AMAM) United States $0.103B 0.00
SQZ Biotechnologies (SQZ) United States $0.087B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00